The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an mRNA respiratory syncytial virus (RSV) ...

A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

The pandemic's volatility affected all public companies, but some saw their business deeply transformed. Here's how three of ...

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly illnesses. That's why there's a specific immunization schedule laid out ...

This year's flu strain is not completely covered by the vaccine, leading to more ... are encountering an increased number of respiratory syncytial virus and norovirus cases. COVID-19 cases are ...

The Tri-State area is experiencing a rise in several viral illnesses, with the flu being the most prevalent, according to a community announcement from Meritus Health.

Generated $40.0 million Gross Revenue and $35.8 million Net Revenue in FY 2024.Record Export Wholesale Revenue: Generated $19.4 million in FY 2024 representing a 107% increase over FY 2023.Record ...

Lee has been doing a lot to keep her family safe. She keeps a health preparation checklist based on emerging disease risks ...

The rapid mutation rate of the virus (faster than coronaviruses) suggests that vaccines will be far behind the virus and ... in lethal virus infection animal model trials for COVID, RSV, Influenza, ...